Insulet Stock

Insulet Liabilities 2025

Insulet Liabilities

1.88 B USD

Ticker

PODD

ISIN

US45784P1012

WKN

A0MQX8

In 2025, Insulet's total liabilities amounted to 1.88 B USD, a 1.11% difference from the 1.86 B USD total liabilities in the previous year.

Insulet Aktienanalyse

What does Insulet do?

Insulet Corp is an American company that was founded in 2000 and is headquartered in Acton, Massachusetts. Its goal is to improve the quality of life for people with diabetes by developing innovative products that make living with this chronic disease easier. Insulet Corp is known for its product "OmniPod." The OmniPod is a wireless, portable disposable insulin pump system that offers an alternative option to traditional pumping and insulin delivery systems. The OmniPod system consists of two small devices: a pod worn on the skin and a PDM (Personal Diabetes Manager) that regulates insulin delivery. The pod contains an insulin reservoir that communicates wirelessly with the PDM. The insulin dose is administered directly into the body without needles or tubes. Insulet Corp is also introducing the "OmniPod DASH System." This new system combines the proven design of the OmniPod pod with a new color touchscreen handheld device that allows for even easier operation. The DASH system also offers the ability to control insulin dosing from a smartphone, which can be taken with diabetics wherever they go. The success of the OmniPod system has made Insulet Corp a leading company in the diabetes industry. The company has also developed and introduced products and services in other areas of diabetes treatment. Insulet Corp has developed another product called "Amigo." This product is a personalized travel and training program for people who require insulin. Amigo offers specialized and personalized training to support diabetics in managing complex situations. It also offers diet and exercise plans to make living with diabetes easier. Insulet Corp has also developed a software called "OmniPod Horizon." This software is a closed-loop system that automatically adjusts insulin dosing to keep blood sugar levels within the target range. The system is currently in the development phase and is expected to be released in 2020. Insulet Corp has also developed a program called the "OmniPod Partner Program," which targets doctors and pharmacists. The program provides training and educational materials for healthcare providers to help them better treat and manage their patients. Since 2009, Insulet Corp has been listed on the NASDAQ stock exchange and has continuously evolved since then. The company currently has over 1500 employees and operates in North America, Europe, and the Middle East. Insulet Corp is a company focused on the development of innovative, life-changing products and services. It is expected to continue to play a significant role in improving the quality of life for people with diabetes in the future. Insulet ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Insulet's Liabilities

Insulet's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Insulet's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Insulet's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Insulet's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Insulet’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Insulet stock

What is the level of liabilities of Insulet this year?

Insulet has a debt balance of 1.88 B USD this year.

What were the liabilities of Insulet compared to the previous year?

The liabilities of Insulet have increased by 1.11% increased compared to the previous year.

What are the consequences of high debt for investors of Insulet?

High liabilities can pose a risk for investors of Insulet, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Insulet?

Low liabilities mean that Insulet has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Insulet affect the company?

An increase in liabilities of Insulet can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Insulet affect the company?

A decrease in the liabilities of Insulet can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Insulet?

Some factors that can influence the liabilities of Insulet include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Insulet so important for investors?

The liabilities of Insulet are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Insulet take to modify the liabilities?

To change its liabilities, Insulet can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Insulet pay?

Over the past 12 months, Insulet paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Insulet is expected to pay a dividend of 0 USD.

What is the dividend yield of Insulet?

The current dividend yield of Insulet is .

When does Insulet pay dividends?

Insulet pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Insulet?

Insulet paid dividends every year for the past 0 years.

What is the dividend of Insulet?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Insulet located?

Insulet is assigned to the 'Health' sector.

Wann musste ich die Aktien von Insulet kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Insulet from 10/8/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/8/2025.

When did Insulet pay the last dividend?

The last dividend was paid out on 10/8/2025.

What was the dividend of Insulet in the year 2024?

In the year 2024, Insulet distributed 0 USD as dividends.

In which currency does Insulet pay out the dividend?

The dividends of Insulet are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Insulet stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Insulet

Our stock analysis for Insulet Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Insulet Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.